Cargando…

Effects of the PARP Inhibitor Olaparib on the Response of Human Peripheral Blood Leukocytes to Bacterial Challenge or Oxidative Stress

Prior studies demonstrate the activation of poly-(ADP-ribose) polymerase 1 (PARP1) in various pathophysiological conditions, including sepsis. We have assessed the effect of olaparib, a clinically used PARP1 inhibitor, on the responses of human peripheral blood leukocytes (PBMCs) obtained from healt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos, Sidneia Sousa, Brunialti, Milena Karina Coló, Rodrigues, Larissa de Oliveira Cavalcanti Peres, Liberatore, Ana Maria Alvim, Koh, Ivan Hong Jun, Martins, Vanessa, Soriano, Francisco Garcia, Szabo, Csaba, Salomão, Reinaldo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221060/ https://www.ncbi.nlm.nih.gov/pubmed/35740913 http://dx.doi.org/10.3390/biom12060788

Ejemplares similares

Efficacy of Clinically Used PARP Inhibitors in a Murine Model of Acute Lung Injury
por: Martins, Vanessa, et al.
Publicado: (2022)

Epigenetic Regulation in Sepsis, Role in Pathophysiology and Therapeutic Perspective
por: Falcão-Holanda, Renata Brito, et al.
Publicado: (2021)

Flow Cytometry of Human Primary Epidermal and Follicular Keratinocytes
por: Gragnani, Alfredo, et al.
Publicado: (2008)

Increased Percentages of T Helper Cells Producing IL-17 and Monocytes Expressing Markers of Alternative Activation in Patients with Sepsis
por: Colo Brunialti, Milena Karina, et al.
Publicado: (2012)

Transitional B cells and CD21low in patients with ataxia-telangiectasia
por: Bichuetti-Silva, Danielli Christinni, et al.
Publicado: (2015)

Expression of CD40, CD40L and IgM production in patients with ataxia-telangiectasia
por: Pereira, Camila Teles Machado, et al.
Publicado: (2015)

Effect of preoperative pregabalin on analgesia and interleukins after lumbotomy: prospective, randomized, comparative, double-blind study
por: Santiago, Ana Ellen Queiroz, et al.
Publicado: (2019)

Glucose metabolism is upregulated in the mononuclear cell proteome during sepsis and supports endotoxin-tolerant cell function
por: Ferreira, Bianca Lima, et al.
Publicado: (2022)

T helper type cytokines in sepsis: time-shared variance and correlation with organ dysfunction and hospital mortality
por: Costa, Ramon Teixeira, et al.
Publicado: (2019)

Combined Transcriptome and Proteome Leukocyte’s Profiling Reveals Up-Regulated Module of Genes/Proteins Related to Low Density Neutrophils and Impaired Transcription and Translation Processes in Clinical Sepsis
por: Leite, Giuseppe Gianini Figueirêdo, et al.
Publicado: (2021)

Role of Cystathionine β-Synthase and 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation, Migration, and Bioenergetics of Murine Breast Cancer Cells
por: Santos, Sidneia Sousa, et al.
Publicado: (2023)

Expression of genes belonging to the interacting TLR cascades, NADPH-oxidase and mitochondrial oxidative phosphorylation in septic patients
por: Nucci, Laura A., et al.
Publicado: (2017)

Modulation of monocytes in septic patients: preserved phagocytic activity, increased ROS and NO generation, and decreased production of inflammatory cytokines
por: Santos, Sidnéia S., et al.
Publicado: (2016)

PARP inhibitor olaparib sensitizes cholangiocarcinoma cells to radiation
por: Mao, Yize, et al.
Publicado: (2018)

Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis
por: Sharma, Narendra Kumar, et al.
Publicado: (2019)

Cytokine Kinetics in Febrile Neutropenic Children: Insights on the Usefulness as Sepsis Biomarkers, Influence of Filgrastim, and Behavior of the IL-23/IL-17 Pathway
por: de Araujo, Orlei Ribeiro, et al.
Publicado: (2017)

Increased leukocyte oxidative metabolism in severe sepsis and septic shock correlates with organ dysfunction and mortality
por: Martins, P, et al.
Publicado: (2006)

Downregulation of IL-6 and preserved reactive oxygen species production in human monocytes tolerized by lipopolysaccharide and challenged with Toll-like receptor agonists and whole Gram-negative and Gram-positive bacteria
por: Fernandes, Maria da Luz, et al.
Publicado: (2008)

The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
por: Ordóñez, José Luis, et al.
Publicado: (2015)

Potentiation of Peptide Receptor Radionuclide Therapy by the PARP Inhibitor Olaparib
por: Nonnekens, Julie, et al.
Publicado: (2016)

PET Imaging of PARP Expression Using (18)F-Olaparib
por: Wilson, Thomas C., et al.
Publicado: (2019)

Patterns of Gene Expression in Peripheral Blood Mononuclear Cells and Outcomes from Patients with Sepsis Secondary to Community Acquired Pneumonia
por: Severino, Patricia, et al.
Publicado: (2014)

Gene expression profiling of mononuclear cells from patients with sepsis secondary to community-acquired pneumonia
por: Severino, Patricia, et al.
Publicado: (2014)

Proteomic study revealed cellular assembly and lipid metabolism dysregulation in sepsis secondary to community-acquired pneumonia
por: Sharma, Narendra Kumar, et al.
Publicado: (2017)

Increased Serum IL 6 Associated With Mortality and Cognitive Impairment in Elderly Brazilians
por: Caldeira, Marcelo, et al.
Publicado: (2020)

ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib()
por: Wang, Chen, et al.
Publicado: (2017)

Rapamycin sensitizes cancer cells to growth inhibition by the PARP inhibitor olaparib
por: Osoegawa, Atsushi, et al.
Publicado: (2017)

Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
por: Ordóñez, José Luis, et al.
Publicado: (2017)

Olaparib‐Based Photoaffinity Probes for PARP‐1 Detection in Living Cells
por: Voorneveld, Jim, et al.
Publicado: (2020)

PARP inhibitor Olaparib increases the sensitization to radiotherapy in FaDu cells
por: Liu, Chuan, et al.
Publicado: (2020)

Expression of cell surface receptors and oxidative metabolism modulation in the clinical continuum of sepsis
por: Martins, Paulo S, et al.
Publicado: (2008)

An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma
por: Nile, Donna L., et al.
Publicado: (2016)

The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma
por: Park, Hye Jeong, et al.
Publicado: (2018)

PARP inhibitor olaparib sensitizes esophageal carcinoma cells to fractionated proton irradiation
por: Kageyama, Shun-ichiro, et al.
Publicado: (2020)

Recurrent Cervical Cancer Treated Successfully with Single-Agent PARP-Inhibitor, Olaparib
por: Gross, Maya, et al.
Publicado: (2022)

Understanding COVID-19 progression with longitudinal peripheral blood mononuclear cell proteomics: Changes in the cellular proteome over time
por: Figueirêdo Leite, Giuseppe Gianini, et al.
Publicado: (2023)

Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib
por: Daemen, Anneleen, et al.
Publicado: (2012)

Discovery of a potent olaparib–chlorambucil hybrid inhibitor of PARP1 for the treatment of cancer
por: Qin, Hongyu, et al.
Publicado: (2023)

External quality assessment for CD4 + T-lymphocyte count test: Performance of the Brazilian public health laboratories network
por: Gaspar, Pâmela Cristina, et al.
Publicado: (2018)

The PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2′-deoxycytidine lesions
por: Orta, Manuel Luis, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pls0a4o9cf2u0017famb398qfc